🇮🇳IN
Sign In
SP

SPARC

NSE

Sun Pharma Advanced Research Company Limited

₹175.74

+0.22(+0.13%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into SPARC. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SPARC exposure summary

Sun Pharma Advanced Research Company Limited reports a single business segment, Pharmaceutical Research and Development. Sun Pharma Advanced Research Company Limited is a constituent of 2 indices. It is part of the Sun Pharma Group business group.

Index memberships2
Business groupSun Pharma Group

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer